We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Chinese Bird Flu Strains Retain Specificity for Avian Receptors

By LabMedica International staff writers
Posted on 23 Mar 2015
Print article
Image: A new analysis suggest that two deadly flu viruses, variants of subtypes H10N8 and H6N1, have not acquired changes that would allow them to infect people easily (Photo courtesy of the Scripps Research Institute).
Image: A new analysis suggest that two deadly flu viruses, variants of subtypes H10N8 and H6N1, have not acquired changes that would allow them to infect people easily (Photo courtesy of the Scripps Research Institute).
A team of molecular virologists found no indication of a looming "bird flu" pandemic when they determined in laboratory studies that two strains of bird flu that had sickened and killed several individuals in China were better adapted to bird cell receptors and only bound weakly to the human analogs.

Investigators at The Scripps Research Institute (La Jolla, CA, USA) examined the two influenza subtypes H10N8 (which had infected and killed a 73-year-old woman from Jiangxi Province in late 2013) and H6N1 (which caused a nonfatal illness in a 20-year-old Taiwanese woman in June 2013). To this end they produced copies in cell culture of the viral hemagglutinin (HA) proteins based on genetic sequences obtained from Chinese scientists.

Results of binding assays, sialoside glycan microarray analysis, and X-ray crystallography studies revealed that both strains preferentially interacted with avian receptor analogs rather than human ones. Furthermore, introduction of mutations into the receptor-binding site known to convert other HA subtypes from avian to human receptor specificity failed to switch preference to human receptors.

"These bird flu viruses seem able to bind to receptors on host cells in different ways and thus can probably mutate in different ways to jump to humans—so we should not be complacent about our ability to predict the viral changes required to get a pandemic," said senior author Dr. Ian A. Wilson, professor of structural biology at the Scripps Research Institute. "Determining whether a bird flu strain has truly jumped the species barrier will therefore continue to require detailed receptor-binding and structural studies like these."

Results of studies on the bird flu subtypes were published in two papers that were published in the March 11, 2015, issue of the journal Cell Host & Microbe.

Related Links:

The Scripps Research Institute 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.